Summary
This prediction ended on 31.12.18 with a price of €60.56. The prediction for Bayer AG disappointed with a performance of -21.17%. christoph_elias has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 2.667% | 2.667% | 114.686% | -21.954% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by christoph_elias for this prediction
In the thread Bayer AG diskutieren
christoph-elias stimmt der Buy-Einschätzung von DirectorDealer zu
christoph-elias stimmt am 27.09.2018 der Buy-Einschätzung von DirectorDealer mit dem Kursziel 79,926€ zu.
Überschrift: Director's Dealing: Buy
(Laufzeit überschritten)